Share on Pinterest Research shows that using sleep apps may increase stress in people with insomnia. Image Credit: janiecbros/Getty Images A recent study has found that the use of sleep apps may lead ...
• The application includes robust data from the Phase 3 registration program, which demonstrated efficacy of daridorexant on objective and subjective sleep parameters, and an improvement in daytime ...
The FDA has accepted for review the NDA for daridorexant, an investigational dual orexin receptor, for the treatment of insomnia in adults. The Food and Drug Administration (FDA) has accepted for ...
Daridorexant is a dual orexin receptor agonist (DORA) designed for the treatment of insomnia Swiss biotech company Idorsia has submitted a marketing authorisation application to the European Medicines ...
TOKYO, Jul 8, 2020 - (JCN Newswire) - - Eisai Co., Ltd. announced today that the new drug application for approval of its in-house-discovered and developed orexin receptor antagonist DAYVIGO (generic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results